Mechanism of Action and Pharmacodynamics
Trimeperidine (Promedolum) is a full agonist at opioid receptors. Its pharmacokinetic parameters are similar to those of morphine, but it has several key pharmacodynamic differences that determine its clinical utility.
- Analgesia: The analgesic effect of trimeperidine is 2 to 4 times weaker than that of morphine.
- Effect on Respiration: The drug suppresses the respiratory center to a significantly lesser degree. This is a critical property that allows its use in pediatric and obstetric practice without a high risk of fetal or neonatal asphyxia.
- Effect on Smooth Muscle: This is the most important distinction from classical opiates. While morphine causes smooth muscle spasm, trimeperidine exhibits a pronounced antispasmodic effect on the bronchi and ureters. Its spasmogenic action on the intestines and biliary tract is also significantly weaker.
- Effect on the Uterus: The drug stimulates the myometrium, increasing its tone and contractile activity.
Indications for Use
Due to its favorable combination of analgesic and antispasmodic effects, trimeperidine has specific clinical indications:
- Severe Pain Syndrome: Used for severe trauma, oncological diseases, and in the postoperative period to relieve acute pain.
- Premedication: Used for sedation and preparing patients for surgical interventions.
- Obstetric Analgesia: Serves as a drug of choice in obstetrics. This is because it is relatively safe for fetal respiration while simultaneously stimulating labor activity by increasing myometrial tone.
- Colic (Renal, Biliary): Effective pain relief is achieved through the relaxation of the smooth muscle of the ureters and biliary tract (antispasmodic component).
Side Effects and Contraindications
Like other narcotic analgesics, trimeperidine requires strict regulation, monitoring, and controlled prescription.
- Adverse Reactions: Possible side effects include dyspeptic disorders (nausea and vomiting due to effects on the chemoreceptor trigger zone), general weakness, and dizziness.
- Risk of Dependence: Systematic use inevitably leads to drug dependence (both psychological and physical craving for the drug develops).
- Contraindications: The primary limitation for use is respiratory failure. Although the risk of respiratory depression is lower compared to morphine, it still persists and can be fatal if baseline respiratory function is compromised.
Formulations and Dosing
The drug is available in enteral and parenteral dosage forms and is strictly prescription-controlled.
- Tablets: Available in 25 mg doses. Administered orally, 1–2 tablets per dose. The maximum single dose (MSD) for oral administration is 50 mg, and the maximum daily dose (MDD) is 160 mg.
- Solution for Injection: Available in 1% and 2% concentrations in 1 mL ampoules. Administered subcutaneously (SC) at a dose of 10–20 mg. The maximum single dose (MSD) for subcutaneous injection is 40 mg.